IL2 and systemic lupus erythematosus: To replicate and extend these findings, we here applied this technology to three additional selected blood samples: (i) an IFNhi SLE patient with concomitant high circulating IL-2 levels; (ii) an age- and sex-matched IFNlow SLE patient; and (iii) an age- and sex- matched healthy donor.